Beneficial role of vitamin K supplementation on insulin sensitivity, glucose metabolism, and the reduced risk of type 2 diabetes: A review

Nutrition

Volumn 32, Issue 7-8, 2016, Pages 732-739

  Manna, Prasenjit ^a   Kalita, Jatin ^a  

^a CSIR NORTH EAST INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Anti inflammatory; Glucose tolerance; Insulin sensitivity; Lipid lowering; Reduced risk of T2 D; Vitamin K

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; FARNOQUINONE; INTERLEUKIN 6; MENAQUINONE; OSTEOCALCIN; PHYTOMENADIONE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; INSULIN; VITAMIN; VITAMIN K GROUP;

ANTIINFLAMMATORY ACTIVITY; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CYTOKINE PRODUCTION; DIETARY INTAKE; DRUG EFFICACY; DRUG RESPONSE; ENZYME ACTIVITY; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESPONSE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENT; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; INSULIN; INSULIN RESISTANCE; RISK REDUCTION BEHAVIOR; VITAMIN K; VITAMINS;

EID: 84964662010     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.01.011     Document Type: Review

References (63)

1. Shenkin A. Micronutrients in health and disease. Postgrad Med J 2006, 82:559-567.
2. Da Silva M.S., Rudkowska I. Dairy nutrients and their effect on inflammatory profile in molecular studies. Mol Nutr Food Res 2015, 59:1249-1263.
3. Martini L.A., Catania A.S., Ferreira S.R. Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutr Rev 2010, 68:341-354.
4. Mooradian A.D., Failla M., Hoogwerf B., Maryniuk M., Wylie-Rosett J. Selected vitamins and minerals in diabetes. Diabetes Care 1994, 17:464-479.
5. Mooradian A.D., Morley J.E. Micronutrient status in diabetes mellitus. Am J Clin Nutr 1987, 45:877-895.
6. Rasekhi H., Karandish M., Jalali M.T., Mohammad-Shahi M., Zarei M., Saki A., et al. The effect of vitamin K1 supplementation on sensitivity and insulin resistance via osteocalcin in prediabetic women: a double-blind randomized controlled clinical trial. Eur J Clin Nutr 2015, 69:891-895.
7. Yoshida M., Booth S.L., Meigs J.B., Saltzman E., Jacques P.F. Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am J Clin Nutr 2008, 88:210-215.
8. Yoshida M., Jacques P.F., Meigs J.B., Saltzman E., Shea M.K., Gundberg C., et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 2008, 31:2092-2096.
9. Kumar R., Binkley N., Vella A. Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr 2010, 92:1528-1532.
10. Beulens J.W., van der A D.L., Grobbee D.E., Sluijs I., Spijkerman A.M., van der Schouw Y.T. Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care 2010, 33:1699-1705.
11. Ibarrola-Jurado N., Salas-Salvado J., Martinez-Gonzalez M.A., Bullo M. Dietary phylloquinone intake and risk of type 2 diabetes in elderly subjects at high risk of cardiovascular disease. Am J Clin Nutr 2012, 96:1113-1118.
12. Stafford D.W. The vitamin K cycle. J Thromb Haemost 2005, 3:1873-1878.
13. Booth S.L., Suttie J.W. Dietary intake and adequacy of vitamin K. J Nutr 1998, 128:785-788.
14. Booth S.L. Roles for vitamin K beyond coagulation. Annu Rev Nutr 2009, 29:89-110.
15. Shearer M.J., Fu X., Booth S.L. Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Adv Nutr 2012, 3:182-195.
16. Sakamoto N., Nishiike T., Iguchi H., Sakamoto K. Relationship between acute insulin response and vitamin K intake in healthy young male volunteers. Diabetes Nutr Metab 1999, 12:37-41.
17. Dietary reference intakes for vitamin a, vitamin k, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc 2000, National Research Council, National Academy Press, Washington, DC.
18. Pan Y., Jackson R.T. Dietary phylloquinone intakes and metabolic syndrome in US young adults. J Am Coll Nutr 2009, 28:369-379.
19. Choi H.J., Yu J., Choi H., An J.H., Kim S.W., Park K.S., et al. Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial. Diabetes Care 2011, 34:e147.
20. Dam V., Dalmeijer G.W., Vermeer C., Drummen N.E., Knapen M.H., van der Schouw Y.T., et al. Association between vitamin k and the metabolic syndrome: a 10-year follow-up study in adults. J Clin Endocrinol Metab 2015, 100:2472-2479.
21. Peeters P.H., Beckers C.G., Hogervorst J.M., Collette H.J. Effect on breast cancer screening response in The Netherlands of inviting women for an additional scientific investigation. J Epidemiol Community Health 1994, 48:175-177.
22. Muller M., Grobbee D.E., Aleman A., Bots M., van der Schouw Y.T. Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis 2007, 190:143-149.
23. Cranenburg E.C., Koos R., Schurgers L.J., Magdeleyns E.J., Schoonbrood T.H., Landewe R.B., et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010, 104:811-822.
24. Schurgers L.J., Cranenburg E.C., Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost 2008, 100:593-603.
25. Varsha M.K., Thiagarajan R., Manikandan R., Dhanasekaran G. Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress, as well as inhibiting NF-kappaB activation and iNOS expression in rat pancreas. Nutrition 2015, 31:214-222.
26. Sai Varsha M.K., Raman T., Manikandan R. Inhibition of diabetic-cataract by vitamin K1 involves modulation of hyperglycemia-induced alterations to lens calcium homeostasis. Exp Eye Res 2014, 128:73-82.
27. Iwamoto J., Seki A., Sato Y., Matsumoto H., Takeda T., Yeh J.K. Vitamin K(2) prevents hyperglycemia and cancellous osteopenia in rats with streptozotocin-induced type 1 diabetes. Calcif Tissue Int 2011, 88:162-168.
28. Raza H., John A. Streptozotocin-induced cytotoxicity, oxidative stress, and mitochondrial dysfunction in human hepatoma HepG2 cells. Int J Mol Sci 2012, 13:5751-5767.
29. Khalil A., Youssef G.A., Al-Saeed H.F. Protective role of vitamin K against impaired glucose homeostasis in ovariectomized exercised and nonexercised rats. Nat Sci 2014, 12:1-9.
30. Booth S.L., Centi A., Smith S.R., Gundberg C. The role of osteocalcin in human glucose metabolism: marker or mediator?. Nat Rev Endocrinol 2013, 9:43-55.
31. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
32. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008, 105:5266-5270.
33. Pittas A.G., Harris S.S., Eliades M., Stark P., Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009, 94:827-832.
34. Saleem U., Mosley T.H., Kullo I.J. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010, 30:1474-1478.
35. Gravenstein K.S., Napora J.K., Short R.G., Ramachandran R., Carlson O.D., Metter E.J., et al. Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism. J Clin Endocrinol Metab 2011, 96:E884-E890.
36. Truong J.T., Fu X., Saltzman E., Al Rajabi A., Dallal G.E., Gundberg C.M., et al. Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K. J Nutr 2012, 142:936-941.
37. Veldhuis-Vlug A.G., Fliers E., Bisschop P.H. Bone as a regulator of glucose metabolism. Neth J Med 2013, 71:396-400.
38. Gundberg C.M., Markowitz M.E., Mizruchi M., Rosen J.F. Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 1985, 60:736-739.
39. Sokoll L.J., Booth S.L., Davidson K.W., Dallal G.E., Sadowski J.A. Diurnal variation in total and undercarboxylated osteocalcin: influence of increased dietary phylloquinone. Calcif Tissue Int 1998, 62:447-452.
40. Karsenty G., Ferron M. The contribution of bone to whole-organism physiology. Nature 2012, 481:314-320.
41. Lee A.J., Hodges S., Eastell R. Measurement of osteocalcin. Ann Clin Biochem 2000, 37:432-446.
42. Gundberg C.M., Nieman S.D., Abrams S., Rosen H. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 1998, 83:3258-3266.
43. Rabe K., Lehrke M., Parhofer K.G., Broedl U.C. Adipokines and insulin resistance. Mol Med 2008, 14:741-751.
44. Zhao Y.F., Feng D.D., Chen C. Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes. Int J Biochem Cell Biol 2006, 38:804-819.
45. Dunmore S.J., Brown J.E. The role of adipokines in beta-cell failure of type 2 diabetes. J Endocrinol 2013, 216:T37-T45.
46. Juanola-Falgarona M., Salas-Salvado J., Estruch R., Portillo M.P., Casas R., Miranda J., et al. Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk. Cardiovasc Diabetol 2013, 12:7.
47. Ye R., Scherer P.E. Adiponectin, driver or passenger on the road to insulin sensitivity?. Mol Metab 2013, 2:133-141.
48. Rasekhi H., Karandish M., Jalali M.T., Mohammadshahi M., Zarei M., Saki A., et al. Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes: a double-blind randomized controlled clinical trial. J Diabetes Metab Disord 2015, 14:1.
49. Knapen M.H., Schurgers L.J., Shearer M.J., Newman P., Theuwissen E., Vermeer C. Association of vitamin K status with adiponectin and body composition in healthy subjects: uncarboxylated osteocalcin is not associated with fat mass and body weight. Br J Nutr 2012, 108:1017-1024.
50. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
51. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
52. Ohsaki Y., Shirakawa H., Miura A., Giriwono P.E., Sato S., Ohashi A., et al. Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor kappaB through the repression of IKKalpha/beta phosphorylation. J Nutr Biochem 2010, 21:1120-1126.
53. Reddi K., Henderson B., Meghji S., Wilson M., Poole S., Hopper C., et al. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 1995, 7:287-290.
54. Shea M.K., Dallal G.E., Dawson-Hughes B., Ordovas J.M., O'Donnell C.J., Gundberg C.M., et al. Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr 2008, 88:356-363.
55. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 2005, 115:1111-1119.
56. Vollenweider P., von Eckardstein A., Widmann C. HDLs, diabetes, and metabolic syndrome. Handb Exp Pharmacol 2015, 224:405-421.
57. Kawashima H., Nakajima Y., Matubara Y., Nakanowatari J., Fukuta T., Mizuno S., et al. Effects of vitamin K2 (menatetrenone) on atherosclerosis and blood coagulation in hypercholesterolemic rabbits. Jpn J Pharmacol 1997, 75:135-143.
58. Sogabe N., Maruyama R., Baba O., Hosoi T., Goseki-Sone M. Effects of long-term vitamin K(1) (phylloquinone) or vitamin K supplementation on body composition and serum parameters in rats. Bone 2011, 48:1036-1042.
59. Nagasawa Y., Fujii M., Kajimoto Y., Imai E., Hori M. Vitamin K2 and serum cholesterol in patients on continuous ambulatory peritoneal dialysis. Lancet 1998, 351:724.
60. Kolahi S., Pourghassem Gargari B., Mesgari Abbasi M., Asghari Jafarabadi M., Ghamarzad Shishavan N. Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study. Nutr Res Pract 2015, 9:186-191.
61. Beulens J.W., Booth S.L., van den Heuvel E.G., Stoecklin E., Baka A., Vermeer C. The role of menaquinones (vitamin K(2)) in human health. Br J Nutr 2013, 110:1357-1368.
62. Booth S.L., Al Rajabi A. Determinants of vitamin K status in humans. Vitam Horm 2008, 78:1-22.
63. Vitamin K2 added for nutritional purposes in foods for particular nutritional uses, food supplements and foods intended for the general population and Vitamin K2 as a source of vitamin K added for nutritional purposes to foodstuffs, in the context of Regulation (EC) N° 258/97[1] - Scientific Opinion of the Panel on Dietetic Products 2008, EFSA Panel on Dietetic Products, Nutrition and Allergies, European Food Safety Authority, Parma, Italy.